DIANA HARDY: Open Payments
NPI 1578743332 · MENOMINEE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 13 payments from 8 companies in 2025. Trend: 2023 $175 · 2024 $87 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $214 |
| Madrigal Pharmaceuticals | 1 | $99 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| PFIZER INC. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: VRAYLAR, REZDIFFRA, TRELEGY ELLIPTA, NURTEC ODT, Wegovy, Cologuard Collection Kit, Auvelity, CAPLYTA.
Industry payments across MI — which companies pay providers there.
